StockClub
XVIPFXvivo Perfusion AB (publ)$ --
Xvivo Perfusion AB (publ)

Xvivo Perfusion AB (publ)

XVIPF

$ -

-

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

analyticsIncome Statement Summary

FY2025 Full YearUpdated: 12/31/2025

Revenue

attach_money
810M SEK
YoY -1.5%

Operating Income

bar_chart
93M SEK
YoY +5.0%

Net Income

verified
25M SEK
YoY -85.4%

EPS

pie_chart
0.8SEK
YoY -85.4%

Quarterly Performance

Quarterly revenue and net income trend

RevenueOperating IncomeNet Income
No quarterly data available

Full-Year Progress

FY2025
Net Income Progress71.4%Below Target
Revenue Progress810.3M
Revenue Forecast798.8M
Net Income Progress25.1M
Net Income Forecast35.1M

Income Statement Details

Item
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
Cost of revenue
Gross profit
810
278
532
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
100
299
377
717
93
Interest expense
Income before tax
Income tax expense
Net income
44
38
13
25

Unlock Long-Term Income Statement Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.